For example, in a preclinical mouse model of hepatocellular carcinoma (HCC) showed that cabozantinib administration promotes the recruitment of neutrophils and reduced intratumor CD8+ PD1+ T cells and Tregs while enhanced memory/effector T cell proportions in the blood12. Here, CD8A is linked to hepatocellular carcinoma.